Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma
by on Tuesday, July 10th, 2012 | No Comments
Condition: Hodgkins Lymphoma
Intervention: Biological: allogeneic donor derived LMP specific cytotoxic T-lymphocyte
Sponsors: New York Medical College; New York Medical College; Baylor College of Medicine; M.D. Anderson Cancer Center; Beckman Research Institute; Johns Hopkins University; Ohio State University; University of Utah; University of Michigan
Not yet recruiting – verified July 2012
Read more from the original source: Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma